HEART FAILURE
Clinical trials for HEART FAILURE explained in plain language.
Never miss a new study
Get alerted when new HEART FAILURE trials appear
Sign up with your email to follow new studies for HEART FAILURE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Heart failure drug trial halted early
Disease control TerminatedThis study tested a new drug called XXB750 in 136 people with heart failure and reduced heart function. The goal was to see if the drug could lower a marker of heart strain (NT-proBNP) and was safe. The trial was stopped early, so results are limited.
Matched conditions: HEART FAILURE
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 11:20 UTC
-
Heart failure drug trial halted midway
Disease control TerminatedThis study tested a single dose of an experimental drug called REGN5381 in 89 people with chronic heart failure whose hearts pump less blood than normal. The goal was to check safety, side effects, and how the drug affects a key heart stress marker (NT-proBNP). The trial was term…
Matched conditions: HEART FAILURE
Phase: PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 11:19 UTC
-
Mini heart pump trial halted early: hope for advanced heart failure?
Disease control TerminatedThis study tested a small heart pump (HeartWare MVAD) in 11 people with severe heart failure. The goal was to see if the device could help them live longer and feel better. The trial was stopped early, so results are limited, but the pump is designed to support the heart long-ter…
Matched conditions: HEART FAILURE
Phase: NA • Sponsor: Medtronic Cardiac Rhythm and Heart Failure • Aim: Disease control
Last updated May 26, 2026 11:11 UTC
-
Heart-Kidney drug combo study halted early
Disease control TerminatedThis study tested whether adding a new drug called AZD5462 to the standard medicine dapagliflozin could help people with both heart failure and moderate kidney disease. The trial was stopped early and only included 8 participants. The main goal was to see how the drug combination…
Matched conditions: HEART FAILURE
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 26, 2026 11:10 UTC
-
New heart failure drug shows promise in Mid-Stage trial
Disease control TerminatedThis study tested a new drug called LY3540378 in 332 adults with worsening chronic heart failure where the heart pumps normally but doesn't fill properly. The goal was to see if the drug could improve heart function and safety compared to a placebo. The trial was terminated early…
Matched conditions: HEART FAILURE
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
Heart surgery recovery: can patients manage their own precautions?
Symptom relief TerminatedThis study looked at whether letting patients manage their own sternal precautions after heart surgery leads to better quality of life without increasing pain or complications. Ten adults who had heart surgery were followed for up to a year. The goal was to see if a self-managed …
Matched conditions: HEART FAILURE
Phase: NA • Sponsor: University of Chicago • Aim: Symptom relief
Last updated May 26, 2026 11:17 UTC
-
Heart failure drug trial halted: did ponsegromab ease symptoms?
Symptom relief TerminatedThis study tested whether a medicine called Ponsegromab could improve symptoms and quality of life in adults with heart failure. Participants received either the drug or a placebo as a shot every four weeks for about 9 months. The trial was stopped early, so results are limited. …
Matched conditions: HEART FAILURE
Phase: PHASE2 • Sponsor: Pfizer • Aim: Symptom relief
Last updated May 18, 2026 12:01 UTC
-
Heart failure wearable study halted early
Knowledge-focused TerminatedThis study aimed to see if a special wearable shirt could predict heart failure hospitalizations by collecting data from sensors. It planned to enroll up to 500 people with heart failure, but was stopped early with only 13 participants. The goal was to develop an algorithm to war…
Matched conditions: HEART FAILURE
Sponsor: Nanowear Inc. • Aim: Knowledge-focused
Last updated May 26, 2026 11:16 UTC
-
Which pacing mode boosts blood pressure best in heart failure?
Knowledge-focused TerminatedThis study looked at how different pacing modes affect blood pressure in people with heart failure who have a special pacemaker (CRT). Researchers measured the highest systolic blood pressure achieved with each mode. The goal was to find which setting works best acutely, but the …
Matched conditions: HEART FAILURE
Phase: NA • Sponsor: CMC Ambroise Paré • Aim: Knowledge-focused
Last updated May 22, 2026 13:51 UTC
-
Wearable Defibrillator's heart sound accuracy under review
Knowledge-focused TerminatedThis study looked at whether a wearable defibrillator (WCD) can accurately record heart sounds in people with heart failure. About 60 adults with heart failure and weak heart pumping (ejection fraction 40% or less) took part. The goal was to compare the WCD's recordings to a stan…
Matched conditions: HEART FAILURE
Sponsor: Zoll Medical Corporation • Aim: Knowledge-focused
Last updated May 18, 2026 12:01 UTC